Sign up Australia
Proactive Investors - Run By Investors For Investors
Why invest in BCT?
Bluechiip: THE INVESTMENT CASE
INVESTMENT OVERVIEW

Bluechiip: Access latest PPT from Proactive's CEO Sessions

Andrew McLellan discussed with investors wiresless tracking technology.
Bluechiip: Access latest PPT from Proactive's CEO Sessions
INVESTMENT OVERVIEW: BCT The Big Picture
Andrew McLellan, MD, bluechiip

Bluechiip's (ASX:BCT) managing director, Andrew McLellan, joined Proactive's CEO Sessions in Sydney on Tuesday 14th March and Melbourne on Wednesday 15th March.

Bluechiip has developed an IT based temperature and identification tracking solution for biosamples in the health and life sciences industry.

The company has a growing partner pipeline and growing revenues.

 

ACCESS THE FULL PRESENTATION HERE

 

View full BCT profile View Profile

Bluechiip Timeline

Newswire
August 11 2016
Newswire
December 15 2015
Newswire
September 16 2015

Related Articles

remote meeting
August 15 2018
The acquisition of MeetingZone earlier this year has been called “transformational” by LoopUp bosses
Vault online software in the cloud image
August 08 2018
The company has achieved strong sales on the back of its risk and safety management software systems.
Data servers
July 31 2018
The company is expected to list on the main board of the LSE in September

© Proactive Investors 2018

Proactive Investors Australia PTY LTD ACN:132787654 ABN:19132787654.

Market Indices, Commodities and Regulatory News Headlines copyright © Morningstar. Data delayed 15 minutes unless otherwise indicated. Terms of use